134 related articles for article (PubMed ID: 12738113)
1. Drug rash with eosinophilia and systemic symptoms syndrome and renal toxicity with a nevirapine-containing regimen in a pregnant patient with human immunodeficiency virus.
Knudtson E; Para M; Boswell H; Fan-Havard P
Obstet Gynecol; 2003 May; 101(5 Pt 2):1094-7. PubMed ID: 12738113
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine-associated hepatotoxicity and rash among HIV-infected pregnant women in Kenya.
Peters PJ; Polle N; Zeh C; Masaba R; Borkowf CB; Oyaro B; Omolo P; Ogindo P; Ndivo R; Angira F; Lando R; Fowler MG; Weidle PJ; Thomas TK
J Int Assoc Physicians AIDS Care (Chic); 2012; 11(2):142-9. PubMed ID: 22020069
[TBL] [Abstract][Full Text] [Related]
3. Hypersensitivity syndrome (DRESS) and meningoencephalitis associated with nevirapine therapy.
Lanzafame M; Rovere P; De Checchi G; Trevenzoli M; Turazzini M; Parrinello A
Scand J Infect Dis; 2001; 33(6):475-6. PubMed ID: 11450872
[TBL] [Abstract][Full Text] [Related]
4. DRESS (drug rash with eosinophilia and systemic symptoms) syndrome associated with nevirapine therapy.
Bourezane Y; Salard D; Hoen B; Vandel S; Drobacheff C; Laurent R
Clin Infect Dis; 1998 Nov; 27(5):1321-2. PubMed ID: 9827291
[No Abstract] [Full Text] [Related]
5. Nevirapine-induced side effects in pregnant women: experience of a Brazilian university hospital.
Kondo W; Carraro EA; Prandel E; Dias JM; Perini J; Macedo RL; Cornelsen TC; Sbalquiero R; Sasaki Md
Braz J Infect Dis; 2007 Dec; 11(6):544-8. PubMed ID: 18327464
[TBL] [Abstract][Full Text] [Related]
6. Nevirapine-associated rash with eosinophilia and systemic symptoms in a child with human immunodeficiency virus infection.
Santos RP; Ramilo O; Barton T
Pediatr Infect Dis J; 2007 Nov; 26(11):1053-6. PubMed ID: 17984815
[TBL] [Abstract][Full Text] [Related]
7. Nelfinavir and nevirapine side effects during pregnancy.
Timmermans S; Tempelman C; Godfried MH; Nellen J; Dieleman J; Sprenger H; Schneider ME; de Wolf F; Boer K; van der Ende ME;
AIDS; 2005 May; 19(8):795-9. PubMed ID: 15867493
[TBL] [Abstract][Full Text] [Related]
8. Third-trimester maternal toxicity with nevirapine use in pregnancy.
Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
[TBL] [Abstract][Full Text] [Related]
9. Safety of nevirapine in pregnancy.
Natarajan U; Pym A; McDonald C; Velisetty P; Edwards SG; Hay P; Welch J; de Ruiter A; Taylor GP; Anderson J
HIV Med; 2007 Jan; 8(1):64-9. PubMed ID: 17305934
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine-induced rash with eosinophilia and systemic symptoms (DRESS).
Gill S; Sagar A; Shankar S; Nair V
Indian J Pharmacol; 2013; 45(4):401-2. PubMed ID: 24014920
[TBL] [Abstract][Full Text] [Related]
11. [Cutaneous, hepatic and hematologic manifestations due to nevirapine: DRESS syndrome?].
Sissoko D; Ajana F; de la Tribonnière X; Baclet V; Mouton Y
Presse Med; 2000 May 27-Jun 3; 29(19):1041-2. PubMed ID: 10874910
[TBL] [Abstract][Full Text] [Related]
12. Adverse events in a cohort of HIV infected pregnant and non-pregnant women treated with nevirapine versus non-nevirapine antiretroviral medication.
Aaron E; Kempf MC; Criniti S; Tedaldi E; Gracely E; Warriner A; Kumar R; Bachmann LH
PLoS One; 2010 Sep; 5(9):e12617. PubMed ID: 20838641
[TBL] [Abstract][Full Text] [Related]
13. Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain.
Bundow D; Rosoff L; Aboulafia DM
AIDS Read; 2001 Nov; 11(11):577-80. PubMed ID: 11789021
[TBL] [Abstract][Full Text] [Related]
14. Liver injury in HIV-1-infected patients receiving non-nucleosides reverse transcriptase inhibitors-based antiretroviral therapy.
Li ZC; Li HJ; Dai LL; Gao YQ; Cai WP; Li HY; Huang XJ; Zhang T; Wu H
Chin Med J (Engl); 2010 Dec; 123(24):3587-90. PubMed ID: 22166636
[TBL] [Abstract][Full Text] [Related]
15. DRESS syndrome associated with nevirapine therapy.
Claudio GA; Martin AF; de Dios Perrino S; Velasco AA
Arch Intern Med; 2001 Nov; 161(20):2501-2. PubMed ID: 11700164
[No Abstract] [Full Text] [Related]
16. Nevirapine-associated toxicity in HIV-infected Thai men and women, including pregnant women.
Phanuphak N; Apornpong T; Teeratakulpisarn S; Chaithongwongwatthana S; Taweepolcharoen C; Mangclaviraj S; Limpongsanurak S; Jadwattanakul T; Eiamapichart P; Luesomboon W; Apisarnthanarak A; Kamudhamas A; Tangsathapornpong A; Vitavasiri C; Singhakowinta N; Attakornwattana V; Kriengsinyot R; Methajittiphun P; Chunloy K; Preetiyathorn W; Aumchantr T; Toro P; Abrams EJ; El-Sadr W; Phanuphak P
HIV Med; 2007 Sep; 8(6):357-66. PubMed ID: 17661843
[TBL] [Abstract][Full Text] [Related]
17. Incidence of nevirapine-associated hepatitis in an antenatal clinic.
Black V; Rees H
S Afr Med J; 2008 Feb; 98(2):116-8. PubMed ID: 18350206
[TBL] [Abstract][Full Text] [Related]
18. Safety issues about nevirapine administration in HIV-infected pregnant women.
Manfredi R; Calza L
J Acquir Immune Defic Syndr; 2007 Jul; 45(3):365-8. PubMed ID: 17592340
[No Abstract] [Full Text] [Related]
19. Hepatotoxicity with antiretroviral treatment of pregnant women.
Hill JB; Sheffield JS; Zeeman GG; Wendel GD
Obstet Gynecol; 2001 Nov; 98(5 Pt 2):909-11. PubMed ID: 11704198
[TBL] [Abstract][Full Text] [Related]
20. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
